<DOC>
	<DOCNO>NCT00048984</DOCNO>
	<brief_summary>Diagnostic trial study genetic difference patient Ewing 's sarcoma . Genetic testing may help predict cancer respond treatment allow doctor plan effective therapy .</brief_summary>
	<brief_title>Diagnostic Study Tumor Characteristics Patients With Ewing 's Sarcoma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To develop mechanism collect distribute tumor specimens various investigator , system prioritize develop quality-control measure central data report study undertake . II . To determine prognostic significance translocation subtype Ewing sarcoma ; determine prognostic significance translocation negative Ewing sarcoma . III . To determine prognostic significance MRD detection bone marrow specimens RT-PCR determination EWS-ETS fusion gene . IV . To determine whether serum level IGF1 , IGFBP3 significance outcome patient Ewing sarcoma . V. To determine whether RNA expression profile perform diagnostic specimen allow identification newer prognostic category potentially new molecular target treatment Ewing sarcoma . VI . To identify new treatment target therapy . Further test potential target carry hope expedite translation finding clinic . VII . To establish bank Ewing sarcoma xenograft SCID/Beige mouse . VIII . To establish clinical proteomics resource investigation alter signal molecule pathogenesis Ewing sarcoma . OUTLINE : This multicenter study . Patients undergo various specimen collection , include bone marrow aspirate , paraffin-embedded block tumor tissue slide tumor tissue , blood specimen . These specimen collect , , chemotherapy regimen , follow-up , time recurrence . Translocation study perform specimen identify fusion gene , specifically EWS-ETS . Serum IGF1 IFGBP3 level determine . Bone marrow assess minimal residual disease use reverse-transcriptase polymerase chain reaction .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<criteria>Newly diagnose recurrent Ewing 's sarcoma Availability follow specimen : Paraffinembedded block 20 unstained slide 13 thick ( 50 micron ) section initial biopsy Pretreatment serum whole blood Concurrent therapy require</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>